C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2011
11/24/2011	CA2799764A1 Mtor selective kinase inhibitors
11/24/2011	CA2799579A1 Chemical compounds, compositions and methods for kinase modulation
11/24/2011	CA2799517A1 Method for purifying a fused pyrrolocarbazole derivative
11/24/2011	CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/23/2011	EP2388002A2 Antidepressant containing heterocyclic compound having specific structure
11/23/2011	EP2388001A2 Age retardant containing heterocyclic compound having specific structure
11/23/2011	EP2388000A2 Neuroprotectant containing heterocyclic compound having specific structure
11/23/2011	EP2387557A1 Process for the preparation of n-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-n-methyl-acetamide
11/23/2011	EP2387315A1 IMIDAZO[1,2-a]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS
11/23/2011	EP1651653B1 Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
11/23/2011	EP1569937B1 C-6 modified indazolylpyrrolotriazines
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	CN1777610B Water-soluble mono-pegylated tetrapyrrole derivatives for photodynamic therapy and method of production
11/23/2011	CN102257029A Pi-electron conjugated compound, manufacturing method therefor, and pi-electron conjugated polymer obtained using same
11/23/2011	CN102256982A Process for making a crystalline zilpaterol salt
11/23/2011	CN102256981A Process for the preparation of anagrelide and analogues
11/23/2011	CN102256980A 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives
11/23/2011	CN102256979A Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
11/23/2011	CN102256978A Process for the preparation of tetrazine derivatives
11/23/2011	CN102256966A Soluble mtor complexes and modulators thereof
11/23/2011	CN102250102A Alpha(beta)quinoline-oligopolycthylene glycol phthalocyanine zinc and preparation method thereof
11/23/2011	CN102250101A Bis-alpha-quinoline-low molecular polyethylene glycol phthalocyanine zinc and preparation method thereof
11/23/2011	CN102250100A Indolactam alkaloid and use of indolactam alkaloid in preparation of antimalarial drugs
11/23/2011	CN102250099A Non-peptide thrombin inhibitors as well as preparation method and medical application thereof
11/23/2011	CN102250098A Pyrazinones compound
11/23/2011	CN102250097A 6-alkyloxy-2-alkylthio-8-azapurine and synthesis thereof
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN101775019B Melotenine and pharmaceutical composition as well as preparation method and application thereof
11/23/2011	CN101691372B Aildenafil citrate crystal form C and preparation method and application thereof
11/23/2011	CN101591340B 5,10,15,20-tetra-(5-drewamine amyl)-chlorin, preparation and application thereof in field of medicaments and pesticides
11/22/2011	US8063208 Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
11/22/2011	US8063204 Benzothiazole and benzoxazole linked pyrrolo[2,1-c] [1, 4] benzodiazepine hybrids as novel antitumour agents and process for the preparation thereof
11/22/2011	US8063203 Compositions and methods of making a photoactive agent
11/22/2011	US8063056 Anti-cancer cyclopenta [g]quinazonline compounds
11/22/2011	US8063053 1-(arylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazoles as 5-hydroxytryptamine-6 ligands
11/22/2011	US8063048 Acetylenyl-pyrazolo-pyrimidine derivatives
11/22/2011	US8063040 Triazabenzo[E]azulene derivatives for the treatment of tumors
11/22/2011	US8063038 Heterocyclic condensed compounds useful as antidiuretic agents
11/22/2011	US8063032 Histamine H3 inverse agonists and antagonists and methods of use thereof
11/22/2011	US8063028 Heterocyclic antiviral compounds
11/22/2011	US8062769 Indolocarbazole compound for use in organic electroluminescent device and organic electroluminescent device
11/22/2011	CA2513655C Use of tryptanthrin compounds for immune potentiation
11/22/2011	CA2484395C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
11/17/2011	WO2011143669A2 Compositions and methods for treating neoplasia, inflammatory disease and other disorders
11/17/2011	WO2011143646A1 Fused bicyclic kinase inhibitors
11/17/2011	WO2011143495A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
11/17/2011	WO2011143459A1 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
11/17/2011	WO2011143366A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/17/2011	WO2011142825A2 Novel sulfur containing compounds
11/17/2011	WO2011142184A1 Composite of liquid porphyrin derivative and nanocarbon material, method for producing the same, charge-transporting material, and electronic component
11/17/2011	WO2011141713A1 New bicyclic compounds as pi3-k and mtor inhibitors
11/17/2011	WO2011141474A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/17/2011	WO2011141396A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/17/2011	WO2011140858A1 Aildenafil citrate crystal form o, preparation method and use thereof
11/17/2011	WO2011113798A3 Inhibitors of semicarabazide - sensitive amine oxidase
11/17/2011	WO2011112596A3 Method of making a cyclic guanidine from a guanidinium salt and a weak acid and coating compositions containing same
11/17/2011	WO2011084434A3 Aza-ring fused indole and indoline derivatives
11/17/2011	WO2011082271A3 Substituted triazolo-pyrimidine compounds
11/17/2011	US20110282057 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
11/17/2011	US20110282056 Protein kinase inhibitors and use thereof
11/17/2011	US20110281927 Deuterium-enriched doripenem
11/17/2011	US20110281881 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281875 Inhibitors of IAP
11/17/2011	US20110281866 Heterocyclic kinase inhibitors
11/17/2011	US20110281863 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
11/17/2011	US20110281859 Novel heterocyclic compounds as metap-2 inhibitors
11/17/2011	US20110281857 Pi3k/mtor kinase inhibitors
11/17/2011	US20110281845 Organic compounds
11/17/2011	US20110281842 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
11/17/2011	US20110281832 Organic compounds
11/17/2011	US20110281821 Modulators of Mitotic Kinases
11/17/2011	US20110280867 Heterocyclic aspartyl protease inhibitors
11/17/2011	CA2799381A1 Male contraceptive compositions and methods of use
11/17/2011	CA2799156A1 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
11/17/2011	CA2799020A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/16/2011	EP2386559A1 Cytotoxiv agents comprising new tomaymycin derivatives and their therapeutic use
11/16/2011	EP2386556A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands
11/16/2011	EP2385946A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and tuerapeutic application thereof
11/16/2011	EP2385945A1 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
11/16/2011	EP2209789B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/16/2011	EP1931676B1 Pyrazolopyrimidines as protein kinase inhibitors
11/16/2011	EP1899345B1 Pyrrolotriazine compounds useful as kinase inhibitors
11/16/2011	CN102245612A Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
11/16/2011	CN102245611A mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/P13K/AKT pathway
11/16/2011	CN102245610A Pyrrolotriazine kinase inhibitors
11/16/2011	CN102245609A Imidazopyridazinecarbonitriles useful as kinase inhibitors
11/16/2011	CN102245608A Azolotriazinone melanin concentrating hormone receptor-1 antagonists
11/16/2011	CN102241681A Preparation method of carboxyl-substituted metal phthalocyanine
11/16/2011	CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011	CN102241679A Process for the synthesis of 4h-imidazo [1,5-a] [1,4] benzodiazepines, in particular midazolam and salts thereof
11/16/2011	CN102241678A Antitumor effect and application of alicyclic structure-containing compound
11/16/2011	CN101426771B Process for manufacturing diazepine derivatives
11/16/2011	CN101397299B Method for synthesizing pyrazole[3,4-d] pyrimidinone
11/16/2011	CN101330915B Pharmaceutical compositions containing Erythrine mulungu derivatives and processes for their production
11/15/2011	US8058451 Enhanced solubility in common solvents; ion sensor; removal odors; water and air pollution control
11/15/2011	US8058438 Eszopiclone process
11/15/2011	US8058425 Purine derivatives as kinase inhibitors
11/15/2011	US8058288 Amido compounds and their use as pharmaceuticals
11/15/2011	US8058275 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP

1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 573